Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Mango Sciences
AddedFeb 16, 2024
UpdatedJun 18, 2026
Mango Sciences

Mango Sciences

Series A

Mango Sciences: An AI-driven precision medicine firm, bridging underrepresented patients to healthcare.

HQ
Boston, MA, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Mango Sciences, founded with the mission to bridge underrepresented patients to precision medicine, leverages AI-driven data science to improve healthcare outcomes. The company focuses on emerging markets, offering solutions tailored for hospitals, life science companies, and financial institutions. Their core services aim to integrate vast amounts of patient data to provide personalized treatment plans, enhancing the accessibility and effectiveness of medical care for millions of underserved individuals.

Notable figures affiliated with Mango Sciences include experts in data science, healthcare, and AI technology, though specific names are not publicly highlighted. The company has achieved significant milestones in expanding precision medicine to previously overlooked populations, contributing to more equitable healthcare solutions. By addressing the gap in medical data representation, Mango Sciences is making a substantial impact on global health equity and the advancement of personalized medicine.

Mango Sciences - Similar Companies

ScienceIO logo

ScienceIO

science.io

Precision Health AI logo

Precision Health AI

MedlyticsAi logo

MedlyticsAi

Zephyr AI logo

Zephyr AI

zephyrai.bio

Medeloop logo

Medeloop

medeloop.ai

Unite Genomics logo

Unite Genomics

BioAI Health logo

BioAI Health

bioaihealth.com

Health at Scale logo

Health at Scale

healthatscale.com

Phenomix Sciences logo

Phenomix Sciences

Humanity logo

Humanity

humanity.email

bioSyntagma logo

bioSyntagma

biosyntagma.com

Carenostics logo

Carenostics

carenostics.com

Axiomedix logo

Axiomedix

axiomedix.com

Ambit.AI logo

Ambit.AI

ambit.ai

meMR Health logo

meMR Health

Mango Sciences - Quick Facts

Who are Mango Sciences' competitors?

Companies similar to Mango Sciences include ScienceIO, Precision Health AI, MedlyticsAi and Zephyr AI.

When was Mango Sciences founded?

Mango Sciences was founded in 2019.

Where is Mango Sciences' headquarters located?

Mango Sciences' headquarters is located in Boston, MA, US.

How much has Mango Sciences raised to-date?

As of Oct 26, 2021, Mango Sciences has raised a total of $3.5M (USD).

How many employees does Mango Sciences have?

Mango Sciences has 27 employees as of Feb 5, 2024.

Mango Sciences - Classification

Industry
  • Hospitals
Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Data
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Precision Medicine
Tags
  • AI Operations
  • Healthtech
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 10 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7371Computer Programming Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified